Azelastine

{x}Pharmacological Category: Second Generation
{x}MOA: Competes with histamine for H1-receptor sites on effector cells and inhibits the release of histamine; when used intranasally, reduces hyper-reactivity of the airways; increases the motility of bronchial epithelial cilia, improving mucociliary transport
{b}Adverse Effects: >10%: Bitter taste, headache, drowsiness, cold symptoms, rhinitis, and cough
2-10%: dyesthesia, fatigue, contact dermatitis, weight gain, dysgeusia, xerostomia, myalgia, conjunct